silver has been researched along with imipenem, anhydrous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
George, SC; Jayachandran, VP; Kalarikkal, N; Lewu, FB; Mohan, S; Oluwafemi, OS; Songca, SP; Thomas, S | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Dolatabadi, S; Zendegani, E | 1 |
Al Jurayyan, AN; Alahmedi, S; Alharbi, NS; Almazyed, AO; Almosallam, MA; Alobaidi, AS; Khaled, JM; Nauman, K; Siddiqi, MZ | 1 |
4 other study(ies) available for silver and imipenem, anhydrous
Article | Year |
---|---|
Completely green synthesis of dextrose reduced silver nanoparticles, its antimicrobial and sensing properties.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Escherichia coli; Gelatin; Glucose; Green Chemistry Technology; Hydrogen Peroxide; Imipenem; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron; Oxidation-Reduction; Pseudomonas aeruginosa; Sensitivity and Specificity; Silver; Silver Nitrate; Solubility; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Surface Plasmon Resonance | 2014 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Humans; Imipenem; Iran; Metal Nanoparticles; Microbial Sensitivity Tests; Silver | 2020 |
A synergic action of colistin, imipenem, and silver nanoparticles against pandrug-resistant Acinetobacter baumannii isolated from patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Imipenem; Male; Metal Nanoparticles; Microbial Sensitivity Tests; Silver | 2021 |